Maze Therapeutics Statistics
Total Valuation
MAZE has a market cap or net worth of $1.72 billion. The enterprise value is $1.30 billion.
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAZE has 54.68 million shares outstanding. The number of shares has increased by 88.16% in one year.
| Current Share Class | 54.68M |
| Shares Outstanding | 54.68M |
| Shares Change (YoY) | +88.16% |
| Shares Change (QoQ) | +3.17% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 78.54% |
| Float | 36.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 85.77 |
| Forward PS | 253.51 |
| PB Ratio | 4.13 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 64.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.14, with a Debt / Equity ratio of 0.14.
| Current Ratio | 14.14 |
| Quick Ratio | 13.88 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -59.22 |
Financial Efficiency
Return on equity (ROE) is -37.49% and return on invested capital (ROIC) is -65.87%.
| Return on Equity (ROE) | -37.49% |
| Return on Assets (ROA) | -32.45% |
| Return on Invested Capital (ROIC) | -65.87% |
| Return on Capital Employed (ROCE) | -33.97% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $141,844 |
| Profits Per Employee | -$1.07M |
| Employee Count | 141 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.73% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.73% |
| 50-Day Moving Average | 29.39 |
| 200-Day Moving Average | 31.02 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 627,555 |
Short Selling Information
The latest short interest is 6.68 million, so 12.22% of the outstanding shares have been sold short.
| Short Interest | 6.68M |
| Short Previous Month | 7.53M |
| Short % of Shares Out | 12.22% |
| Short % of Float | 18.51% |
| Short Ratio (days to cover) | 8.84 |
Income Statement
In the last 12 months, MAZE had revenue of $20.00 million and -$151.47 million in losses. Loss per share was -$2.67.
| Revenue | 20.00M |
| Gross Profit | 20.00M |
| Operating Income | -164.16M |
| Pretax Income | -151.47M |
| Net Income | -151.47M |
| EBITDA | -162.45M |
| EBIT | -164.16M |
| Loss Per Share | -$2.67 |
Full Income Statement Balance Sheet
The company has $476.98 million in cash and investments and $59.64 million in debt, with a net cash position of $417.34 million or $7.63 per share.
| Cash & Investments | 476.98M |
| Total Debt | 59.64M |
| Net Cash | 417.34M |
| Net Cash Per Share | $7.63 |
| Equity (Book Value) | 428.55M |
| Book Value Per Share | 7.59 |
| Working Capital | 371.80M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$114.74 million and capital expenditures -$522,000, giving a free cash flow of -$115.26 million.
| Operating Cash Flow | -114.74M |
| Capital Expenditures | -522,000 |
| Depreciation & Amortization | 1.72M |
| Net Borrowing | 39.40M |
| Free Cash Flow | -115.26M |
| FCF Per Share | -$2.11 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -820.82% |
| Pretax Margin | -757.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MAZE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -88.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -8.50% |
| FCF Yield | -6.72% |
Analyst Forecast
The average price target for MAZE is $62.46, which is 99.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $62.46 |
| Price Target Difference | 99.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MAZE has an Altman Z-Score of 10.25 and a Piotroski F-Score of 1.
| Altman Z-Score | 10.25 |
| Piotroski F-Score | 1 |